GeoVax Labs Inc GOVXW:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/01/21 EST
2.40quote price arrow down-0.13 (-6.46%)
Volume
1,112
52 week range
0.49 - 4.48

...

Loading . . .

KEY STATS

  • Open1.88
  • Day High1.88
  • Day Low1.88
  • Prev Close1.88
  • 52 Week High4.48
  • 52 Week High Date02/16/21
  • 52 Week Low0.49
  • 52 Week Low Date10/02/20
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest GeoVax Labs Inc News

There is no recent news for this security.

Latest GOVXW News From Our Partners

February 9, 2021

QUOTE FINDER

Profile

MORE
GeoVax Labs, Inc. (GeoVax) is a clinical-stage biotechnology company. The Company is engaged in developing human vaccines against infectious diseases using its modified vaccine Ankara-virus-like particles (MVA-VLP) vaccine platform. The Company's platform supports in vivo expression of non-infectious virus-like particles (VLPs) from the cells of the person receiving the vaccine. The Company's development programs are focused on vaccines against Human Immunodeficiency Virus...
David Dodd
Chairman
Mark Reynolds CPA
Chief Financial Officer
Address
1900 Lake Park Drive, Suite 380
Smyrna, GA
30080
United States